SINOVAC BIOTECH LTD
SVACIK 0001084201
Revenue (TTM)
$386.01M
+6.8% YoY
FY Dec 2025
Net Income (TTM)
−$13.49M
−193.3% YoY
FY Dec 2025
EPS Diluted (TTM)
−$0.83
−165.4% YoY
FY Dec 2025
Gross Margin
67.9%
FY Dec 2025
Operating Margin
-127.0%
FY Dec 2025
Net Margin
-3.5%
FY Dec 2025
Free Cash Flow (TTM)
−$561.1M
FY Dec 2025
Cash
$488.25M
FY Dec 2025
Total Debt
$498.18M
FY Dec 2025
Shares Outstanding
71.86M sh
FY Dec 2025